-
-
-
-
-
-
-
Clearmind Medicine reports positive safety data for alcohol disorder drug
-
-
-
-
-
-
-
Zenas BioPharma drug meets primary endpoint in multiple sclerosis trial
-
-
-
-
-
-
-
Peijia Medical submits EU regulatory application for heart device
-
-
-
-
-
-
-
uniQure reports sustained enzyme activity in Fabry disease gene therapy trial
-
-
-
-
-
-
-
Denali shares clinical data on enzyme treatments for rare diseases
-
-
-
-
-
-
-
IMUNON restructures operations to focus on phase 3 ovarian cancer trial
-
-
-
-
-
-
-
NorthStrive extends AI drug discovery Phase III timeline to Q2 2026
-
73,954 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

